Auro Vaccines Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 88.19%
(FY 2023)
- Ebitda -8261.11%
(FY 2023)
- Net Worth 113.11%
(FY 2023)
- Total Assets 25.29%
(FY 2023)
About Auro Vaccines
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Madan Mettu, Satakarni Makkapati, and Mylandlahalli Ashwini serve as directors at the Company.
- CIN/LLPIN
U24297TG2021PTC156684
- Company No.
156684
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2021
- Date of AGM
19 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Auro Vaccines?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madan Mettu  | Director | 08-Nov-2021 | Current |
| Satakarni Makkapati | Director | 08-Nov-2021 | Current |
| Mylandlahalli Ashwini | Director | 17-May-2024 | Current |
Financial Performance of Auro Vaccines.
Auro Vaccines Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 88.19% increase in profit. The company's net worth Soared by an impressive increase of 113.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auro Vaccines?
Unlock access to Auro Vaccines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Curateq Biologics Private LimitedActive 4 years 8 months
Madan Mettu and Mylandlahalli Ashwini are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Auro Vaccines?
Auro Vaccines has a workforce of 117 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auro Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auro Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
